XML 46 R35.htm IDEA: XBRL DOCUMENT v3.25.0.1
Equity (Tables)
9 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Common Stock Reserved for Issuance
The Company has shares of common stock reserved for issuance as follows (in thousands):
December 31, 2024
Common stock warrants315 
2010 Plan
Options outstanding11,805 
2021 Plan
Awards outstanding
4,060 
Shares available for future grant40,431 
2021 ESPP9,812 
Options outstanding outside the plans2,638 
Total69,061 
Stock Option Activity
Stock option activities within the Plans as well as outside of the Plans were as follows:
Number of Shares
(in thousands)
Weighted-Average
Exercise Price
Average Remaining Contractual Term
(in years)
Aggregate Intrinsic Value
(in thousands)
Balance, March 31, 202417,480 $4.60 5.72$389,931 
Options exercised(2,941)3.90 
Options forfeited or expired(96)7.30 
Balance, December 31, 202414,443 4.73 5.09702,867 
Vested and exercisable as of December 31, 202410,925 3.74 4.76542,383 
Vested and expected to vest as of December 31, 202414,443 4.73 5.09702,867 
Restricted Stock Unit Activity
The following table summarizes RSU activity (in thousands, except per share information):
Number of SharesWeighted-
Average
Grant Date Fair Value
Unvested balance, March 31, 20242,093 $33.79 
Granted2,905 27.66 
Vested(1,167)31.25 
Forfeited(162)27.12 
Unvested balance, December 31, 20243,669 30.04 
Stock-Based Compensation Expense
Total stock-based compensation expense recognized in the condensed consolidated statements of operations was as follows (in thousands):
Three Months Ended December 31,Nine Months Ended December 31,
2024202320242023
Cost of revenue$2,818 $2,466 $8,373 $7,205 
Research and development4,471 3,080 14,602 8,874 
Sales and marketing6,487 4,060 19,881 12,752 
General and administrative5,592 2,165 11,470 6,742 
Restructuring
— — — 3,646 
Total stock-based compensation expense$19,368 $11,771 $54,326 $39,219